PubMed COVID-19 Clinical Care

CONCLUSION: There are three strategies for developing drugs for antivirals in disorders of the respiratory system, including chemical drugs, herbal medicines or natural products, and biological products. Herbal medicines may provide a new insight and

CONCLUSIONS: A well-designed and implemented healthcare worker safety plan can minimize the risk of SARS-CoV-2 infection for healthcare workers. The lessons learned from operating the nation's largest COVID-19 ACS can be adapted to other environments

CONCLUSION: Patients with uncontrolled asthma and high disease burden, including increased asthma medication intensity, should be identified as risk patients for severe COVID-19. Furthermore, current smoking is strongly associated with COVID-19 death

CONCLUSIONS: Many reported HCP cases experienced occupational COVID-19 exposures, particularly during periods of higher community COVID-19 incidence.

In this paper, an improved COVID-19 model is given to investigate the influence of treatment and media awareness, and a non-linear saturated treatment function is introduced in the model to lay stress on the limited medical conditions. Equilibrium

No abstract

CONCLUSION: A novel, highly successful teaching programme was developed in Northern Ireland to meet the training needs of CSTs resulting in a sustained change to training. Virtual surgical teaching can be as effective as face-to-face didactic

Favipiravir is a potential antiviral drug undergoing clinical trials to manage various viral infections, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Favipiravir possesses antiviral properties against RNA viruses, including

Teleworking has been growing over the decades, arising many challenges to overcome. The COVID-19 pandemic situation accelerated this process. The forms of presentation are varied, homework perhaps is the most frequent. The objective of this study was

CONCLUSION: It is crucial to encourage people to vaccinate in establishing immune barriers. Especially, when the supply is limit, a wiser strategy to restrict the SARS-CoV-2 transmission is equally distributing doses to the same amounts of